The Critical Link Between Cost, Quality, and Outcomes (CQO) and Unique Device Identification (UDI) White Paper

Related Resources

Advisory
This Special Fraud Alert focuses on the specific attributes and practices of PODs that OIG believes produce substantial fraud and abuse risk and pose…
Toolkits/Methodology
How to write a constructive, information-rich comment that clearly communicates and supports its claims to have an impact on regulatory decision…
Advisory
The Food and Drug Administration (FDA) UDI system is being phased in over several years.
White Papers
This white paper explores the realities facing healthcare delivery, some of the new models being developed and what they could mean for the s
Letter/Comment
Recent Guidance on Meaningful Use of EHRs Makes Compliance More Difficult.
Letter/Comment
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Fo